We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TACT icon
11976
PUT
Transact Technologies
TACT
$53.4M
$79K ﹤0.01%
+11,200
New +$99.5K
TTSH
11977
CALL
DELISTED
Tile Shop Holdings
TTSH
$79K ﹤0.01%
12,000
-45,700
-79% -$300K
CSCI
11978
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$79K ﹤0.01%
2,176
-1,696
-44% -$61K
INTZ
11979
CALL
DELISTED
INTRUSION INC NEW
INTZ
$79K ﹤0.01%
+31,800
New +$79K
FENC icon
11980
PUT
Fennec Pharmaceuticals
FENC
$430M
$78K ﹤0.01%
14,000
-19,600
-58% -$98.8K
DWTX
11981
Dogwood Therapeutics
DWTX
$90.1M
$78K ﹤0.01%
+699
New +$102K
AAIC
11982
DELISTED
Arlington Asset Investment Corp.
AAIC
$78K ﹤0.01%
22,386
-31,466
-58% -$109K
BLU
11983
CALL
DELISTED
BELLUS Health Inc.
BLU
$78K ﹤0.01%
11,400
-32,200
-74% -$207K
HYRE
11984
PUT
DELISTED
HyreCar Inc. Common Stock
HYRE
$78K ﹤0.01%
32,600
-22,600
-41% -$69.8K
EVTL icon
11985
PUT
Vertical Aerospace
EVTL
$117M
$77K ﹤0.01%
1,110
-2,830
-72% -$214K
RVPH
11986
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$77K ﹤0.01%
1,565
+146
+10% +$5.83K
SONN
11987
DELISTED
Sonnet BioTherapeutics
SONN
$77K ﹤0.01%
+83
New +$70.2K
AGIL
11988
DELISTED
AgileThought Inc
AGIL
$77K ﹤0.01%
+16,860
New +$83.2K
CDAK
11989
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$77K ﹤0.01%
12,208
-2,084
-15% -$13.1K
EXTN
11990
CALL
DELISTED
Exterran Corporation
EXTN
$77K ﹤0.01%
12,400
-11,200
-47% -$59.7K
NSR
11991
CALL
DELISTED
Nomad Royalty Company Ltd.
NSR
$77K ﹤0.01%
+10,500
New +$73.2K
ADTX
11992
CALL
DELISTED
ADITXT INC
ADTX
0
CURV icon
11993
PUT
Torrid Holdings
CURV
$227M
$76K ﹤0.01%
12,500
-46,700
-79% -$398K
MKTW icon
11994
PUT
MarketWise
MKTW
$50.3M
$76K ﹤0.01%
+805
New +$87.7K
MRKR icon
11995
Marker Therapeutics
MRKR
$22.8M
$76K ﹤0.01%
17,154
-21,026
-55% -$120K
UXIN
11996
CALL
Uxin Ltd
UXIN
$255M
$76K ﹤0.01%
741
-332
-31% -$37.9K
USDP
11997
PUT
DELISTED
USD PARTNERS LP
USDP
$76K ﹤0.01%
+12,700
New +$72.7K
NMTR
11998
DELISTED
9 Meters Biopharma
NMTR
$76K ﹤0.01%
6,308
-7,820
-55% -$107K
ONCS
11999
DELISTED
OncoSec Medical Incorporated
ONCS
$76K ﹤0.01%
3,009
+1,006
+50% +$21.2K
AEG icon
12000
Aegon
AEG
$13.6B
$75K ﹤0.01%
14,843
-20,877
-58% -$106K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.